Julian Wilkins is founder and vice president with PharmaConsult US, Inc. An architect by training, Wilkins commenced his career designing pharmaceutical facilities in Europe. In 1991 he founded a UK based isolator company for the emerging need for pharmaceutical containment. The company carried out many projects worldwide for aseptic and potent containment at all scales of pharmaceutical operation. He moved to the US in 1997 and set up PharmaConsult US in 1999. Since its formation, the company has provided independent advice, design and support for containment projects including Bristol-Myers Squibb, Mallinckrodt, Merck & Co., Pfizer, Sanofi Sythelabo, Seattle Genetics, Schering Plough, Wyeth as well as Apotex, Novex, and Organichem. Wilkins has spoken at many seminars worldwide on the subject of containment and has contributed articles and chapters to periodicals and books on containment. Wilkins is currently co-chair of the ISPE API Community of Practice.